Jes Broeng’s Post

Alzheimer’s – new paper in Nature Treatment of Alzheimer’s and Dementia (AD) remains one of the largest challenges in medicine. Tragically, the few antibody drugs on the market are often associated with serious side effects, such as brain swelling or bleeding. In contrast, increasing scientific evidence indicate positive potential using flickering light therapy for treating AD in a safe manner. This so-called light-based gamma entrainment using sensory stimuli (GENUS) shows considerable potential in both animal and human models. Dating back to 2016, we began work in this area in a collaboration between University of California, Berkeley and DTU - Technical University of Denmark – and have been pioneering novel GENUS solutions for more comfortable and convenient patient use. In the latest Nature, Scientific Reports we demonstrate the efficiency of these new solutions for stimulating the brain: https://lnkd.in/dKiKfh_K The coming years will be highly exciting as we see an increasing number of clinical trials and a rapidly growing global research community. Main credit for this work to my excellent co-authors and leading scientists Luna Skytte Hansen, Marcus Carstensen, Mark Henney, Ngoc Mai Nguyen, Martin William Thorning-Schmidt, Paul Michael Petersen & Tobias Søren Andersen Also a big thank you to the Innovation Fund Denmark for supporting this important work towards a treatment of AD. And finally, a huge congratulations to Marcus Carstensen – recently receiving the Young Researcher Award at the DTU - Technical University of Denmark – well deserved 👏 OptoCeutics DTU Electro DTU Compute DTU Entrepreneurship Vivienne Ming Jan Torleif Pedersen, PhD, MSc David Lindeman Lance Kriegsfeld